Chr. Olesen and Co. A/S Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Chr. Olesen and Co. A/S's estimated annual revenue is currently $30.4M per year.(i)
  • Chr. Olesen and Co. A/S's estimated revenue per employee is $201,000

Employee Data

  • Chr. Olesen and Co. A/S has 151 Employees.(i)
  • Chr. Olesen and Co. A/S grew their employee count by 26% last year.

Chr. Olesen and Co. A/S's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Chr. Olesen and Co. A/S?

Chr. Olesen is a distribution company. We strive to be perceived as the best link between manufactures and customers in distributing high-quality ingredients to the feed, food and pharmaceutical industries all over the world. Reliability is the quality assurance of everything we do.

keywords:N/A

N/A

Total Funding

151

Number of Employees

$30.4M

Revenue (est)

26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Chr. Olesen and Co. A/S News

2022-04-13 - Planilha ajuda produtor a planejar plantio de árvores em ILPF ...

Desde 1º de Janeiro de 2022 a cadeia da produção de proteína animal no Brasil e América Latina conta com uma nova empresa, a NHU/Chr. Olesen...

2019-09-05 - New Market Report on Denmark Vermouth Market, Estimating ...

New Market Report on Denmark Vermouth Market, Estimating for Years 2019-2026, and Prominent Players are, Carlsberg Group Chr. Olesen ...

2019-08-06 - Portable Medical Devices Market 2019-2025 increasing ...

The global portable medical devices market which was represented a CAGR of approximately +9% in the midst of the estimate time span of ...

2019-04-04 - Knight Files Management Information Circular, Warns ...

... of Spepharm B.V., Bionpharma Inc., CoreRx, Inc., Leon Nanodrugs GmbH, Pharmaceutics International, Inc. and Chr. Olesen Synthesis A/S

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$48.2M1516%N/A
#2
$33.3M151-21%$160.4M
#3
$34.1M1518%N/A
#4
$33.9M151N/AN/A
#5
$24.1M151N/AN/A